FOSB and non-small cell lung carcinoma: Furthermore, the expression levels of both FOSB and PCDHB13 were negatively correlated with the clinical status of NSCLC patients, suggesting that the FOSB–PCDHB13 axis may be a promising molecular target for the NSCLC.